Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
The goal of this split-face clinical trial is to test the efficacy of microtox in improving facial skin quality, fine wrinkles, and texture. Participants will:
* be randomly assigned to Group A (which will receive 20 units of neuromodulator on the left side of the forehead and a placebo saline treatment on the right side) or Group B (which will receive 20 units of neuromodulator on the left side of the forehead and 20 units of a different neuromodulator brand on the right side as a comparator)
* have one treatment session at week 0, and two live assessment visits at weeks 2 and 12
* have their pictures taken at each visit to track progress
Phase:
PHASE1
Details
Lead Sponsor:
Kalpna Kay Durairaj, MD, FACS
Collaborator:
Evolus, Inc.
Treatments:
incobotulinumtoxinA prabotulinumtoxin A Saline Solution